Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions

R. Cervera, M. G. Tektonidou, G. Espinosa, A. R. Cabral, E. B. González, D. Erkan, S. Vadya, H. E. Adrogué, M. Solomon, G. Zandman-Goddard, Y. Shoenfeld

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.

Original languageEnglish (US)
Pages (from-to)165-173
Number of pages9
JournalLupus
Volume20
Issue number2
DOIs
StatePublished - Feb 1 2011

    Fingerprint

Keywords

  • Catastrophic antiphospholipid syndrome
  • antiphospholipid antibodies
  • heart valve lesions
  • nephropathy

ASJC Scopus subject areas

  • Rheumatology

Cite this

Cervera, R., Tektonidou, M. G., Espinosa, G., Cabral, A. R., González, E. B., Erkan, D., Vadya, S., Adrogué, H. E., Solomon, M., Zandman-Goddard, G., & Shoenfeld, Y. (2011). Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions. Lupus, 20(2), 165-173. https://doi.org/10.1177/0961203310395051